The Safety and Efficacy of Pyronaridine-artesunate (Pyramax® or Artecom®)in COVID-19 Patients
Condition(s):Covid19Last Updated:January 20, 2021Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Covid19Last Updated:January 20, 2021Not yet recruiting
Condition(s):AmetropiaLast Updated:January 6, 2021Not yet recruiting
Condition(s):Schizophrenia; Major Depressive DisorderLast Updated:December 1, 2020Recruiting
Condition(s):Iron-deficiency; AnemiaLast Updated:November 13, 2020Completed
Condition(s):Primary Angle Closure Glaucoma; Primary Angle ClosureLast Updated:November 10, 2020Recruiting
Condition(s):AmetropiaLast Updated:December 30, 2020Not yet recruiting
Condition(s):Covid19Last Updated:September 29, 2020Recruiting
Condition(s):Hand Surgery; Orthopedic SurgeryLast Updated:July 29, 2020Completed
Condition(s):Infant Development; Glucose, High BloodLast Updated:September 29, 2020Recruiting
Condition(s):Neovascular Age-related Macular Degeneration; Diabetic Macular Edema; Retinal Vein Occlusion With Macular Edema; Uveitic Macular Edema; Choroidal NeovascularizationLast Updated:November 17, 2020Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.